Display Settings:

Format

Send to:

Choose Destination
    Science. 1991 Jun 21;252(5013):1703-5.

    Selective elimination of HIV-1-infected cells with an interleukin-2 receptor-specific cytotoxin.

    Source

    Laboratory of Infectious Diseases, Dana-Farber Cancer Institute, Boston, MA.

    Abstract

    Infection by human immunodeficiency virus type 1 (HIV-1) is associated with cellular activation and expression of the interleukin-2 (IL-2) receptor. A genetically engineered fusion toxin, DAB486 IL-2, that contains the enzymatic site and translocation domain of diphtheria toxin and the receptor binding domain of IL-2 specifically kills cells that express high-affinity IL-2 receptors. This toxin selectively eliminated the HIV-1-infected cells from mixed cultures of infected and uninfected cells and inhibited production of viral proteins and infectious virus. Thus, cellular activation antigens present a target for early antiviral intervention.

    PMID:
    1904628
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk